Cantor Fitzgerald restated their overweight rating on shares of Anthem, Inc. (NYSE:ANTM) in a research note published on Wednesday morning. The firm currently has a $215.00 price objective on the stock, up from their prior price objective of $210.00.

“This morning, Anthem reported 2Q17 results. Revenue was essentially in line with expectations while adjusted EPS of $3.37 compares to our estimate of $2.90 and FactSet consensus of $3.24.”,” Cantor Fitzgerald’s analyst commented.

Several other equities analysts have also recently weighed in on ANTM. Jefferies Group LLC lifted their target price on Anthem from $172.00 to $177.00 and gave the company a hold rating in a research note on Thursday, March 30th. Deutsche Bank AG started coverage on Anthem in a research note on Wednesday, April 5th. They set a hold rating and a $166.00 target price on the stock. Royal Bank Of Canada reaffirmed an outperform rating and set a $183.00 target price (up previously from $179.00) on shares of Anthem in a research note on Thursday, April 27th. Sanford C. Bernstein lifted their target price on Anthem from $202.00 to $212.00 and gave the company an outperform rating in a research note on Friday, April 28th. Finally, Morgan Stanley started coverage on Anthem in a research note on Tuesday, June 6th. They set an equal weight rating and a $196.00 target price on the stock. Eleven analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of $180.00.

Anthem (NYSE ANTM) opened at 187.79 on Wednesday. Anthem has a one year low of $114.85 and a one year high of $194.94. The stock’s 50 day moving average is $189.83 and its 200 day moving average is $173.24. The stock has a market capitalization of $49.31 billion, a price-to-earnings ratio of 17.76 and a beta of 0.73.

Anthem (NYSE:ANTM) last released its earnings results on Wednesday, July 26th. The company reported $3.37 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.23 by $0.14. Anthem had a return on equity of 12.93% and a net margin of 3.24%. The company had revenue of $22.20 billion for the quarter, compared to analysts’ expectations of $22.25 billion. During the same quarter in the previous year, the business posted $3.33 EPS. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. On average, equities analysts forecast that Anthem will post $11.81 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Anthem’s (ANTM) “Overweight” Rating Reiterated at Cantor Fitzgerald” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.watchlistnews.com/anthems-antm-overweight-rating-reiterated-at-cantor-fitzgerald/1462275.html.

The business also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be issued a $0.70 dividend. This is a positive change from Anthem’s previous quarterly dividend of $0.65. This represents a $2.80 annualized dividend and a yield of 1.49%. The ex-dividend date of this dividend is Thursday, September 7th. Anthem’s payout ratio is 24.62%.

In related news, Director Ramiro G. Peru sold 2,681 shares of the business’s stock in a transaction that occurred on Tuesday, May 30th. The stock was sold at an average price of $181.58, for a total value of $486,815.98. Following the completion of the sale, the director now directly owns 13,571 shares in the company, valued at approximately $2,464,222.18. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Ronald W. Penczek sold 867 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $187.46, for a total value of $162,527.82. Following the completion of the sale, the senior vice president now owns 1,872 shares of the company’s stock, valued at $350,925.12. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,103 shares of company stock valued at $749,555. Corporate insiders own 0.36% of the company’s stock.

A number of large investors have recently bought and sold shares of the company. FTB Advisors Inc. raised its stake in Anthem by 11.1% in the first quarter. FTB Advisors Inc. now owns 668 shares of the company’s stock valued at $117,000 after buying an additional 67 shares during the period. Westside Investment Management Inc. raised its stake in Anthem by 33.6% in the first quarter. Westside Investment Management Inc. now owns 795 shares of the company’s stock valued at $131,000 after buying an additional 200 shares during the period. Focused Wealth Management Inc bought a new stake in Anthem during the first quarter valued at $149,000. Guardian Life Insurance Co. of America raised its stake in Anthem by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,016 shares of the company’s stock valued at $168,000 after buying an additional 7 shares during the period. Finally, Cedar Wealth Management LLC raised its stake in Anthem by 1.7% in the second quarter. Cedar Wealth Management LLC now owns 908 shares of the company’s stock valued at $171,000 after buying an additional 15 shares during the period. Hedge funds and other institutional investors own 88.70% of the company’s stock.

Anthem Company Profile

Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.

Analyst Recommendations for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.